Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
5 search results for:

Lomustine 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 05-10-2018 | Acute myeloid leukemia | News | Article

    Lomustine benefits older patients with favorable-, intermediate-risk AML

    Adding lomustine to standard chemotherapy with idarubicin and cytarabine significantly improves survival in fit older patients with favorable- or intermediate-risk acute myeloid leukemia, phase III trial data show.

    Published in:
    J Clin Oncol 2018; doi:10.1200/JCO.2018.78.7366 J Clin Oncol 2018; doi:10.1200/JCO.2018.79.3539
  2. 21-11-2017 | Glioblastoma multiforme | News | Article

    Bevacizumab add-on fails to improve glioblastoma OS with lomustine

    Adding bevacizumab to lomustine does not prolong overall survival compared with lomustine alone in patients with progressive glioblastoma, but may delay disease progression, show phase III study data.

    Published in:
    N Engl J Med 2017; 377 : 1954–1963
  3. 07-10-2017 | Glioblastoma multiforme | Article

    Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

    After the early promise shown by the small molecule tyrosine kinase inhibitor axitinib in patients with recurrent glioblastoma in a randomized phase II trial, this report details further investigation following amendment and continuation of the trial. Duerinck J et al. J Neurooncol 2017. doi:10.1007/s11060-017-2629-z

  4. 11-09-2017 | Glioblastoma multiforme | ESMO 2017 | Article
    ESMO 2017

    Regorafenib improves outcomes in relapsed glioblastoma patients

    The phase II REGOMA trial shows that patients with recurrent glioblastoma derive a significant overall survival and disease control benefit from treatment with regorafenib over lomustine.

  5. 27-08-2018 | Glioma | News | Article
    News in brief

    Bevacizumab strikes out in recurrent glioma

    . © 2018 Springer Healthcare part of the Springer Nature group See also: No event-free survival benefit with bevacizumab in pediatric high-grade glioma Bevacizumab add-on fails to improve glioblastoma OS with lomustine

  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.